Modern Wealth Management LLC raised its stake in Danaher Co. (NYSE:DHR – Free Report) by 30.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,087 shares of the conglomerate’s stock after purchasing an additional 254 shares during the period. Modern Wealth Management LLC’s holdings in Danaher were worth $250,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Howard Capital Management Group LLC raised its stake in shares of Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares in the last quarter. D.A. Davidson & CO. lifted its position in shares of Danaher by 2.6% during the 3rd quarter. D.A. Davidson & CO. now owns 13,294 shares of the conglomerate’s stock worth $3,696,000 after buying an additional 343 shares during the period. Townsquare Capital LLC boosted its stake in Danaher by 25.7% in the 3rd quarter. Townsquare Capital LLC now owns 12,466 shares of the conglomerate’s stock valued at $3,466,000 after buying an additional 2,550 shares in the last quarter. Glenmede Trust Co. NA grew its position in Danaher by 0.3% in the third quarter. Glenmede Trust Co. NA now owns 51,553 shares of the conglomerate’s stock valued at $14,333,000 after acquiring an additional 142 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its stake in Danaher by 48.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 67,639 shares of the conglomerate’s stock worth $18,805,000 after acquiring an additional 22,205 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Danaher Trading Down 2.1 %
DHR opened at $205.69 on Friday. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The company has a market cap of $147.01 billion, a price-to-earnings ratio of 38.96, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a 50 day simple moving average of $214.57 and a 200 day simple moving average of $236.90.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company posted $2.09 EPS. On average, sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s payout ratio is presently 24.24%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- Comparing and Trading High PE Ratio Stocks
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- The Most Important Warren Buffett Stock for Investors: His Own
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Stock Market Sectors: What Are They and How Many Are There?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.